Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective inhibitor of PDGF receptor autophosphorylation from Kirin Brewery

Jan. 21, 1998

Vertex describes new MDR-modulating and neuritogenic agents

Jan. 21, 1998

Genzyme Molecular Oncology, Schering-Plough collaborate to make gene therapy a reality

Jan. 21, 1998

Targeted cytotoxic LHRH analogues show potential as Rx for breast cancer

Jan. 21, 1998

Novel gene therapy for chemoprotection of bone marrow found safe in early clinical trials

Jan. 20, 1998

VEGF and FGF receptor TK inhibitors from Zeneca

Jan. 20, 1998

New agents for cancer discovered at Zeneca

Jan. 19, 1998

Paxene tentatively approved by FDA

Jan. 16, 1998

SuperGen cleared to manufacture commercial supplies of Nipent

Jan. 16, 1998

Tyrosine kinase inhibitor shows potential for leukemias

Jan. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...